Sign inJoin waitlistJoin the waitlist

CH

Christopher Heery

Credentials: ·

History

Medical Oncology
2010–2012
Internal Medicine
2007–2010
Medical School
2003–2007

Research

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
Cancer Immunology Research · 2015 · 402 citations
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
Clinical Cancer Research · 2018 · 360 citations
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
The Lancet Oncology · 2017 · First of 18 authors · 246 citations

James Gulley
39 papers
Ravi Madan
34 papers
Marijo Bilusic
9 papers · 1 as a fellow
Julius Strauss
8 papers
WD
William Dahut
6 papers
Fatima Karzai
4 papers
MF
Matthew Frigault
4 papers
PA
Philip Arlen
4 papers
Arun Rajan
3 papers
GC
Geraldine Coyne
3 papers
Jason Redman
3 papers · 1 as a fellow
LF
Les Folio
3 papers